“What is also important to note,” he said, “is that the decrease in blood pressure, lipids and blood glucose were also maintained in those patients taking oral medications.”
Those improvements could eventually help lower the long-term risk of serious obesity-related conditions such as heart disease, stroke, and type 2 diabetes.
As obesity rates continue rising globally, experts believe medications like orforglipron may become part of a new generation of long-term weight management treatments designed not only to help people lose weight — but finally keep it off.
